Tandlæge Laura Boe-Hansen ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 5.1% 5.6% 5.6% 3.7%  
Credit score (0-100)  0 43 39 40 51  
Credit rating  N/A BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 -0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 -398 -142 -128 -106  
EBITDA  0.0 -1,117 -837 -599 -914  
EBIT  0.0 -1,232 -968 -804 -1,125  
Pre-tax profit (PTP)  0.0 222.8 600.4 29.1 597.4  
Net earnings  0.0 173.7 467.7 20.1 465.6  
Pre-tax profit without non-rec. items  0.0 223 600 29.1 597  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 250 480 638 504  
Shareholders equity total  0.0 214 625 588 995  
Interest-bearing liabilities  0.0 1,720 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 2,230 2,127 2,357 2,107  

Net Debt  0.0 1,688 -31.7 -231 -151  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -398 -142 -128 -106  
Gross profit growth  0.0% 0.0% 64.3% 10.1% 17.3%  
Employees  0 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 2,230 2,127 2,357 2,107  
Balance sheet change%  0.0% 0.0% -4.6% 10.8% -10.6%  
Added value  0.0 -1,116.7 -837.0 -672.6 -913.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 1,382 33 -112 -412  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 309.9% 682.2% 629.8% 1,066.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 17.6% 32.7% 6.9% 31.1%  
ROI %  0.0% 20.0% 53.5% 22.7% 77.3%  
ROE %  0.0% 81.3% 111.5% 3.3% 58.8%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 9.6% 29.4% 24.9% 47.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -151.1% 3.8% 38.5% 16.5%  
Gearing %  0.0% 804.6% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 19.8% 12.9% 0.0% 0.0%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.4 0.3 0.3 0.5  
Current Ratio  0.0 0.4 0.3 0.3 0.5  
Cash and cash equivalent  0.0 32.1 31.7 230.6 150.7  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -1,279.1 -994.1 -1,115.1 -455.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 -1,117 -837 -673 -914  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 -1,117 -837 -599 -914  
EBIT / employee  0 -1,232 -968 -804 -1,125  
Net earnings / employee  0 174 468 20 466